Inventor · disambiguated record
Richard Neve
Also filed as: NEVE RICHARD · NEVE RICHARD M · NEVE RICHARD MICHAEL
2 granted patents·10 pending applications·7 citations·filing 1999–2017
54Inventor score
Top patents by PatentIndex Score
12 records- 0169US8198254B2Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancerHU ZHI·Filed 2009·Granted Jun 12, 2012·2 cites·5 claims
- 0260US2011098226A1Small molecular weight TNF receptor multimeric moleculeKENNEDY INST OF RHEUMATOLOGY·Filed 2009·Application pending·0 cites
- 0358US2009203051A1Targets in breast cancer for prognosis or therapyUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 0451US2007031925A1Small molecular weight TNF receptor multimeric moleculeCHERNAJOVSKY YUTI·Filed 2006·Application pending·0 cites
- 0546US2012077694A1Targets in breast cancer for prognosis or therapyGRAY JOE W·Filed 2011·Application pending·0 cites
- 0644US2009011428A1Fluid Membrane-Based Ligand Display System for Live Cell Assays and Disease Diagnosis ApplicationsUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 0743US7070783B1Small molecular weight TNF receptor multimeric moleculeKENNEDY RHEUMATOLOGY INST·Filed 1999·Granted Jul 4, 2006·5 cites·10 claims
- 0842US2005009033A1Breast cancer genesUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 0938US2018036289A1Cobicistat for use in cancer treatmentsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 1037US2023190750A1Methods of treating and preventing cancer drug resistanceGENENTECH INC·Filed 2015·Application pending·0 cites
- 1134US2017204187A1Methods of treating and preventing cancer drug resistanceGENENTECH INC·Filed 2015·Application pending·0 cites
- 1231US2011183336A1Method to Predict Responsiveness of Breast Cancer to Polyamine-Type ChemotherapyUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Neve files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →